Business Description
Palisade Bio Inc
NAICS : 325412
SIC : 2834
ISIN : US6963892046
Description
Financial Strength
7/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 61.62 | |||||
Equity-to-Asset | 0.8 | |||||
Debt-to-Equity | 0.02 | |||||
Debt-to-EBITDA | -0.01 | |||||
Piotroski F-Score | 3/9 | |||||
WACC vs ROIC |
Growth Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year EBITDA Growth Rate | 78 | |||||
3-Year EPS without NRI Growth Rate | 78.8 | |||||
3-Year FCF Growth Rate | 72.6 |
Momentum Rank
2/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 52.91 | |||||
9-Day RSI | 48.98 | |||||
14-Day RSI | 45.27 | |||||
6-1 Month Momentum % | -36.18 | |||||
12-1 Month Momentum % | -78.58 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 4.87 | |||||
Quick Ratio | 4.87 | |||||
Cash Ratio | 4.57 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -298.9 | |||||
Shareholder Yield % | -159.94 |
Profitability Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
FCF Margin % | -4352.84 | |||||
ROE % | -103.74 | |||||
ROA % | -87.21 | |||||
ROIC % | -922.51 | |||||
ROC (Joel Greenblatt) % | -5796.47 | |||||
ROCE % | -102.1 |
GF Value Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PS Ratio | 8.56 | |||||
PB Ratio | 0.4 | |||||
Price-to-Tangible-Book | 0.4 | |||||
EV-to-EBIT | 0.5 | |||||
EV-to-EBITDA | 0.5 | |||||
EV-to-Revenue | -26.78 | |||||
EV-to-Forward-Revenue | 0.76 | |||||
EV-to-FCF | 0.62 | |||||
Price-to-Net-Current-Asset-Value | 0.42 | |||||
Price-to-Net-Cash | 0.46 | |||||
Earnings Yield (Greenblatt) % | 200 | |||||
FCF Yield % | -245.44 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Annualized Return % Â
Total Annual Return % Â
Palisade Bio Inc Executives
DetailsGF Value
Analyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil €) | 0.229 | ||
EPS (TTM) (€) | -21.887 | ||
Beta | 2.5 | ||
Volatility % | 94.4 | ||
14-Day RSI | 45.27 | ||
14-Day ATR (€) | 0.00243 | ||
20-Day SMA (€) | 5.007 | ||
12-1 Month Momentum % | -78.58 | ||
52-Week Range (€) | 4.747499 - 30.824999 | ||
Shares Outstanding (Mil) | 0.94 |
Piotroski F-Score Details
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 3 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Palisade Bio Inc Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Palisade Bio Inc Stock Events
Event | Date | Price(€) | ||
---|---|---|---|---|
No Event Data |
Palisade Bio Inc Frequently Asked Questions
What is Palisade Bio Inc(FRA:7NS0)'s stock price today?
When is next earnings date of Palisade Bio Inc(FRA:7NS0)?
Does Palisade Bio Inc(FRA:7NS0) pay dividends? If so, how much?
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |